DelveInsight's Dermatomyositis Market Insights report includes a comprehensive understanding of current treatment practices, emerging dermatomyositis drugs, market share of individual therapies ...

DelveInsight’s “ Dermatomyositis Market Insight, Epidemiology, and Market Forecast – 2034 ” provides an in-depth analysis of the current landscape and future outlook of the DM market across major ...

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

The dermatomyositis market is expected to witness steady growth over the next decade, driven by increasing awareness, improved diagnostic tools, and advancements in treatment options. The rising ...

The new guideline builds on ACLM's 2022 expert consensus statement to assist clinicians in achieving type 2 diabetes remission using diet as a primary intervention and the " Type 2 Diabetes Bill of ...

The American College of Lifestyle Medicine has published the first clinical practice guideline focusing primarily on lifestyle interventions for diabetes treatment and potential remission of type ...

Video: What to Know About Treatment of Atopic Dermatitis Based on the 2024 AAD Guidelines —Megan Rogge, MD, associate professor of dermatology at UT Health in Houston, shares her opinion on the ...

The guidelines focuse on two weight management medications that have shown superior effectiveness: semaglutide (a GLP-1 receptor agonist) and tirzepatide (a GLP-1/GIP receptor agonist).

With an increasing geographic footprint, it is important for clinicians to be able to find a treatment for coccidioidomycosis ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published new, evidence-based clinical practice guidelines to support the treatment of chronic venous disease (CVD), a common and ...